Streetbeat News

Analyst Ratings

THC

Over the past 3 months, 10 analysts have published their opinion on Tenet Healthcare (NYSE:THC) stock. The company has an average price target of $94.1 with a high of $104.00 and a low of $87.00. The average price target has increased by 9.93% over the past month.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 5:00 pm

AMED

Cantor Fitzgerald has maintained its Neutral rating for Amedisys (NASDAQ:AMED) and raised its price target from $100.00 to $101.00. Amedisys shares are currently trading at $93.61, up 0.11% over the last 24 hours. A move to $101.00 would represent a 7.89% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 5:00 pm

CECO

Needham has maintained its Buy rating for CECO Environmental (NASDAQ:CECO) and increased its price target from $17.00 to $18.00. CECO Environmental's shares are trading up 8.33% over the last 24 hours, at $15.66 per share. A move to $18.00 would account for a 14.91% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 5:00 pm

HES

A significant bullish stance has been taken on Hess (NYSE:HES) by a large investor, as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 60% bullish and 40% bearish. The price of HES is up 2.32% at $164.18. UBS, Morgan Stanley, and Mizuho have maintained their Buy, Overweight, and Neutral ratings on Hess, respectively.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 4:46 pm

MSFT

SPY

Ken Griffin, founder of hedge fund Citadel LLC, expressed concerns about the current stock market rally, suggesting it might be nearing its end. He also discussed the impact of artificial intelligence (AI) on the economy, stating that it could lead to job cuts in some sectors but overall, it is a productivity tool that improves job performance. His comments led to a slight dip in the SPDR S&P 500 ETF Trust (SPY), which later recovered.

Portfolio Pulse from Chris Katje

September 14, 2023 | 4:42 pm

IREN

HC Wainwright & Co. analyst Mike Colonnese maintains a Buy rating on Iris Energy (NASDAQ:IREN) and raises the price target from $10 to $11.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 4:31 pm

MS

A large investor has taken a bullish stance on Morgan Stanley (NYSE:MS), with 10 uncommon options trades spotted. The sentiment of these trades is split 50% bullish and 50% bearish. The trades include 2 puts amounting to $54,642 and 8 calls amounting to $300,250. Whales have been targeting a price range from $80.0 to $95.0 for Morgan Stanley over the last 3 months. HSBC has downgraded its action to Buy with a price target of $99, while Oppenheimer maintains their Outperform rating with a price target of $105.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 4:31 pm

HOTH

EF Hutton analyst Elemer Piros maintains a 'Buy' rating on Hoth Therapeutics (NASDAQ:HOTH) but lowers the price target from $12 to $7.5.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 4:17 pm

FCX

A significant bearish stance has been taken on Freeport-McMoRan (NYSE:FCX) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 30% bullish and 70% bearish. The whales have been targeting a price range from $34.0 to $47.0 for Freeport-McMoRan over the last 3 months. The price of FCX is currently up 3.01% at $40.94, with RSI indicators suggesting the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 4:17 pm

LNC

Jefferies analyst Suneet Kamath maintains an Underperform rating on Lincoln National (NYSE:LNC) and raises the price target from $18 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 4:09 pm